Gene: ZNRD2
Official Full Name: zinc ribbon domain containing 2provided by HGNC
Gene Summary: This antigen is recognized by a subset of anti-centromere antibodies from patients with scleroderma and/or Sjogren's syndrome. Subcellular localization has not yet been established. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00503 | ZNRD2 knockout cell line (HeLa) | Human | ZNRD2 | 1:3~1:6 | Negative | Online Inquiry |
KO04898 | ZNRD2 Knockout cell line (HCT 116) | Human | ZNRD2 | 1:2~1:4 | Negative | Online Inquiry |
KO04899 | ZNRD2 Knockout cell line (HEK293) | Human | ZNRD2 | 1:3~1:6 | Negative | Online Inquiry |
KO04900 | ZNRD2 Knockout cell line (A549) | Human | ZNRD2 | 1:3~1:4 | Negative | Online Inquiry |
ZNRD2 Gene Knockout Cell Lines are specifically engineered cellular models that facilitate the exploration and study of the ZNRD2 gene's functions and associated pathways. The ZNRD2 gene, known for its role in transcriptional regulation and involvement in multiple cellular processes, is crucial for understanding various biological phenomena, including gene expression, cellular differentiation, and growth regulation. The knockout of this gene allows researchers to assess the consequences of its absence on cellular behavior, providing insights into its biological significance.
The primary mechanism of these knockout cell lines revolves around a targeted gene deletion approach, typically utilizing CRISPR-Cas9 technology or similar genomic editing techniques. By disrupting the ZNRD2 gene, researchers can monitor changes in cellular proliferation, signaling pathways, and overall gene expression profiles, thereby elucidating the role of ZNRD2 in diverse physiological and pathological contexts.
In scientific research and clinical settings, ZNRD2 Gene Knockout Cell Lines are invaluable for drug development, disease modeling, and genetic research, paving the way for advancements in understanding cancer, metabolic disorders, and other diseases related to transcriptional dysregulation. Their ability to mirror in vivo conditions makes them a superior choice for both academic research and biopharmaceutical applications.
Compared to traditional cell lines that carry the intact ZNRD2 gene, these knockout lines empower researchers to specifically investigate the functional consequences of the gene's absence, offering unparalleled insights into pathophysiological mechanisms. Furthermore, they save time and resources by providing a controlled environment where experimental variables related to the ZNRD2 gene are meticulously accounted for.
Researchers and clinicians seeking reliable models for gene function studies will find ZNRD2 Gene Knockout Cell Lines indispensable. Their ability to foster detailed, mechanistic understanding offers a competitive edge in the rapidly evolving field of molecular biology. Our company specializes in delivering high-quality biological products, and our expertise ensures that our clients receive rigorously validated cell lines that meet the demands of contemporary scientific inquiry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.